{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:16:33Z","timestamp":1775708193689,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/s0360-3016(03)01621-3","type":"journal-article","created":{"date-parts":[[2004,2,10]],"date-time":"2004-02-10T10:17:53Z","timestamp":1076408273000},"page":"750-757","source":"Crossref","is-referenced-by-count":116,"title":["Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer"],"prefix":"10.1016","volume":"58","author":[{"given":"Chris","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Milosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ants","family":"Toi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Panzarella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Catton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Catton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"Crook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Gospodarowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padraig","family":"Warde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0360-3016(03)01621-3_BIB1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0167-8140(93)90025-4","article-title":"Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix","volume":"26","author":"Hockel","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.20.3.680","article-title":"Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer","volume":"20","author":"Fyles","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1054\/bjoc.2000.1266","article-title":"Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis","volume":"83","author":"Rofstad","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(99)00102-4","article-title":"Oxygenation of head and neck cancer","volume":"53","author":"Brizel","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1200\/JCO.2000.18.6.1351","article-title":"Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer","volume":"18","author":"von Pawel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB6","first-page":"341","article-title":"Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck","volume":"5","author":"Haffty","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0360-3016(93)90350-5","article-title":"Radiobiological studies of PC-3 and DU-145 human prostate cancer cells","volume":"25","author":"Leith","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0360-3016(95)00036-X","article-title":"Polarographic needle electrode measurements of oxygen in rat prostate carcinomas","volume":"33","author":"Yeh","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/1097-0142(20001101)89:9<2018::AID-CNCR19>3.3.CO;2-P","article-title":"Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age","volume":"89","author":"Movsas","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0090-4295(98)00500-7","article-title":"Hypoxic regions exist in human prostate carcinoma","volume":"53","author":"Movsas","year":"1999","journal-title":"Urology"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2307\/3579071","article-title":"Comparing techniques of measuring tumor hypoxia in different murine tumors","volume":"145","author":"Kavanagh","year":"1996","journal-title":"Radiat Res"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB13","series-title":"Practical statistics for medical research","author":"Altman","year":"1991"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(95)00106-9","article-title":"Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases","volume":"32","author":"Brizel","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/02841869409098433","article-title":"Measurement of human tumour oxygenation status by a polarographic needle electrode","volume":"33","author":"Nordsmark","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(97)00328-3","article-title":"Heterogeneity of polarographic oxygen tension measurements in cervix cancer","volume":"39","author":"Wong","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB17","series-title":"SAS for mixed models","author":"Littell","year":"1996"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB18","series-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","article-title":"Quantifying regional hypoxia in human tumors with positron emission tomography of [18F] fluoromisonidazole","volume":"36","author":"Rasey","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl. 1","key":"10.1016\/S0360-3016(03)01621-3_BIB20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0360-3016(01)02028-4","article-title":"A hypoxic ratio of prostate pO2\/muscle pO2 predicts for biochemical failure in prostate cancer patients","volume":"51","author":"Movsas","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1053-4296(98)80046-5","article-title":"Microenvironmental control of gene expression","volume":"8","author":"Dachs","year":"1998","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB23","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0022-5347(01)64775-X","article-title":"Vascular endothelial growth factor (VEGF) expression in human prostate cancer","volume":"157","author":"Ferrer","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(97)00491-3","article-title":"Angiogenesis and prostate cancer","volume":"51","author":"Ferrer","year":"1998","journal-title":"Urology"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB25","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0022-5347(01)64774-8","article-title":"Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic epithelium","volume":"157","author":"Jackson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0090-4295(00)01044-X","article-title":"Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer","volume":"57","author":"Cvetkovic","year":"2001","journal-title":"Urology"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0090-4295(94)80173-8","article-title":"Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy","volume":"44","author":"Hall","year":"1994","journal-title":"Urology"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB28","first-page":"2082","article-title":"Inactivation of the p53 pathway in prostate cancer","volume":"5","author":"Osman","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X","article-title":"Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate","volume":"79","author":"Silberman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB30","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1210\/en.139.11.4672","article-title":"Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts","volume":"139","author":"Levine","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(01)64361-1","article-title":"Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancer","volume":"158","author":"Hartley-Asp","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/S0360-3016(03)01621-3_BIB32","first-page":"4556","article-title":"Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy","volume":"60","author":"Hansen-Algenstaedt","year":"2000","journal-title":"Cancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301603016213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301603016213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T04:51:40Z","timestamp":1550206300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301603016213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0360301603016213"],"URL":"https:\/\/doi.org\/10.1016\/s0360-3016(03)01621-3","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}